2009 IoN News Archive
- Grant for research into new epilepsy treatments
- Professor Martin Rossor has been recognised by the The Alzheimer's Association
- Drug discovery collaboration on inclusion body myositis
- PDS awards Training Fellowship to Institute of Neurology researcher to understand how the brain controls Parkinson’s symptoms
- Alan Thompson to lead UCL Partners Neurological Disorders theme
- World MS Day - Wednesday 27th May - Global initiative to highlight Multiple Sclerosis
- Queen Square leads on new UK recommendations for bladder management which can dramatically improve quality of life in Multiple Sclerosis
- John Hardy most-cited Alzheimer's disease researcher in the UK
- Prestigious awards for Institute researchers
- Drug study offers hope for Alzheimer’s treatment
- Brain activity predicts our choices
- Professor George du Boulay CBE, FRCR, FRCP
- Brain awareness week: the impact of UCL research
- Parkinson's-linked mutation makes neurons vulnerable to calcium-induced death
- Second round of NIHR Senior Investigators announced
- 'Mind-Reading' Experiment Highlights How Brain Records Memories
- Anti-malaria drug does not appear to help with human prion diseases.
- UCL Partners is one of UK’s first Academic Health Science Centres
- "Opening doors for patients with MS"
- Are we as decisive as we think?
- "Magnets stop the nightmare of tinnitus, researchers say."
- Prestigious award for Professor Hugh Bostock
- Untangling the Brain
- Young UCL Investigator Award in neuroimaging techniques
- Brain disease "resistance gene" could offer insights into CJD
- Neurology: A Queen Square Textbook
- Headache: annual evidence update
- Roads closed for powerful MRI scanner delivery
- Long-term risks lower for surgical treatment of carotid stenosis
- Memorandum of collaboration signed
- Professor John Hardy joins the ranks of science greats
- Drug study offers hope for Alzheimer's treatment
- Prestigious award for Professor David Miller
- Magnets stop the nightmare of tinnitus, researchers say.
- Brain activity predicts our choices
- Jon Driver Award
- Professor Sander named recipient of the American Epilepsy Society 2009 Clinical Science Award
- Study highlights effect of brain waves on human behaviour
- New podcast describes the significance and impact of highly cited paper
- NIH Grant for research into inherited neuropathies
- How the brain knows a dog is a dog: concept acquisition in the human brain
- Prof Elizabeth Fisher elected member of the European Molecular Biology Organization (EMBO)
- Locating literacy in the brain
- Dopamine enhances expectation of pleasure in humans
- Queen Square scientists question memory theory
- IoN scientist to front Alzheimer’s Research Trust national appeal
- New doors open to the understanding of the origin of brain tumours
Published: Jul 8, 2013 2:00:00 PM
Published: Jul 5, 2013 5:29:00 PM
Neurodevelopmental, neurodegenerative and neuromuscular disorders associated with defective autophagy
Published: Jun 18, 2013 4:38:00 PM
Published: Jun 10, 2013 4:35:00 PM
IoN scientist to front Alzheimer’s Research Trust national appeal
23 November 2009
Dr Selina Wray (Department of Molecular Neuroscience) is to front a national appeal for the Alzheimer’s Research Trust.
Dr Selina Wray was selected by the UK dementia research charity thanks to her cutting-edge work using stem cells to fight Alzheimer’s disease.
Dr Wray won a fellowship grant from the Alzheimer’s Research Trust in June 2009. She is using stem cells, made from adult skin cells, to study the tau protein, which forms toxic tangles thought to be behind the damage caused by dementia.
The new Alzheimer’s Research Trust appeal features an in-depth look at Dr Wray’s research alongside a letter written by actress Lynda Bellingham to nearly 40,000 of the charity’s supporters. The 2008 appeal, which featured Alzheimer’s Research Trust Patron Sir Cliff Richard, raised nearly £75,000, but the charity is determined to beat that total in 2009.
Speaking about her involvement in the appeal, Dr Wray said: “I’m over the moon to have my work featured in the appeal. Dementia research doesn’t get the attention it deserves and it’s a horrible disease for patients and their families. I want to be part of developing new treatments, which are now more important than ever as our population gets older. It’s an exciting time to be involved in this research and I’m really grateful to the Alzheimer’s Research Trust and its supporters for funding my work.”
Rebecca Wood, Chief Executive of the Alzheimer’s Research Trust, said: “Dr Wray is one of our pioneering researchers and we’re delighted to feature her work in this important appeal. We’re similarly delighted to have the support of Lynda Bellingham who sadly lost her mother to Alzheimer’s. Appeals like this are a crucial way of raising much needed funds for dementia research. The population living with this cruel condition is forecast to double to 1.4 million within a generation – UK researchers hold the key to arresting this worrying trend, we must back them all the way.”